Get started
Author

E Giuffrida

The SPOSIB SB2 Sicilian Cohort: Safety and Effectiveness of Infliximab Biosimilar SB2 in Inflammatory Bowel Diseases, Including Multiple Switches
2020 · Fabio Salvatore Macaluso, Walter Fries, et al. · Inflammatory Bowel Diseases · 49
Ustekinumab in Crohn's disease: Real‐world outcomes from the Sicilian network for inflammatory bowel diseases
2021 · Anna Viola, Marco Muscianisi, et al. · JGH Open · 21
PDF
Severe Activity of Inflammatory Bowel Disease is a Risk Factor for Severe COVID-19
2022 · Fabio Salvatore Macaluso, Alessandra Giuliano, et al. · Inflammatory Bowel Diseases · 19
Effectiveness of Ustekinumab on Crohn‘s Disease Associated Spondyloarthropathy: Real-World Data from the Sicilian Network for Inflammatory Bowel Diseases (SN-IBD)
2020 · Fabio Salvatore Macaluso, Walter Fries, et al. · Expert Opinion on Biological Therapy · 14
Letter: SPOSIB SB2—a Sicilian prospective observational study of IBD patients treated with infliximab biosimilar SB2
2018 · Fabio Salvatore Macaluso, Maria Cappello, et al. · Alimentary Pharmacology & Therapeutics · 9
PDF
Effectiveness of adalimumab for ulcerative colitis: A multicentre, retrospective study of clinical practice in Italy
2021 · Alessandro Vitello, Mauro Grova, et al. · Digestive and Liver Disease · 7
The ocular manifestations in IBD screening (OMIS) questionnaire: pilot study on detection of ocular involvement in inflammatory bowel diseases
2020 · Maria Vadalà, Chiara Davì, et al. · International Ophthalmology · 7
From advanced diagnosis to advanced resection in early neoplastic colorectal lesions: Never-ending and trending topics in the 2020s
2022 · Francesco Auriemma, Sandro Sferrazza, et al. · World Journal of Gastrointestinal Surgery · 4
Risk of Colorectal Cancer in Inflammatory Bowel Disease: Prevention and Monitoring Strategies According With Risk Factors
2021 · Enrica Giuffrida, Michela Mangia, et al. · Clinical Management Issues · 4
PDF
Agreement between patients and physicians on scores of inflammatory bowel disease activity and burden assessed on a telemonitoring platform
2022 · Michela Mangia, Enrica Giuffrida, et al. · Scandinavian Journal of Gastroenterology · 3
P162 Prevalence of nafld (non alcoholic fatty liver disease) and fibrosis in inflammatory bowel disease: the impact of traditional risk factors, intestinal inflammation and genetic phenotype
2020 · B Scrivo, C Celsa, et al. · Journal of Crohn s and Colitis · 3
PDF
P425 SPOSIB SB2: a Sicilian prospective observational study of patients with inflammatory bowel disease treated with infliximab biosimilar SB2
2020 · F S Macaluso, W Fries, et al. · Journal of Crohn s and Colitis · 2
[Innovative genetic, clinical and endocrinologic aspects in young females affected by premature ovarian insufficiency].
2010 · L Ciotta, I Pagano, et al. · PubMed · 2
Pc.01.3 Severe Activity of Inflammatory Bowel Disease Is a Risk Factor for Severe Covid-19: Data From the Sicilian Network for Inflammatory Bowel Disease (sn-ibd)
2021 · F.S. Macaluso, A. Giuliano, et al. · Digestive and Liver Disease · 1
PDF
P114 A screening tool for the early diagnosis of extraintestinal manifestations in inflammatory bowel disease: the EMAIL questionnaire
2020 · A Busacca, G Ingrassia Strano, et al. · Journal of Crohn s and Colitis · 1
PDF
Su1549: THE PRACTICAL USE OF AN E-HEALTH PLATFORM FOR INFLAMMATORY BOWEL DISEASE PATIENTS: VALIDATION OF THE IBD TOOL WEB-BASED TELE-MONITORING SYSTEM
2022 · Enrica Giuffrida, Michela Mangia, et al. · Gastroenterology
P353 Agreement between patients, senior and junior physicians on disease activity and burden scoring in inflammatory bowel disease, using a tele-monitoring platform
2022 · M Mangia, E Giuffrida, et al. · Journal of Crohn s and Colitis
PDF
P256 The practical use of an eHealth platform for inflammatory bowel disease patients: the validation of the IBD Tool web-based tele-monitoring system
2022 · E Giuffrida, M Mangia, et al. · Journal of Crohn s and Colitis
PDF
Agreement between patients and physicians on scores of inflammatory bowel disease activity and burden assessed on a telemonitoring platform
2022 · Mangia, Michela, Giuffrida, Enrica, et al. · Figshare
P069 Artificial intelligence (AI)-filtered Videos for Accelerated Scoring of Colonoscopy Videos in Ulcerative Colitis Clinical Trials
2021 · B Gutierrez Becker, E Giuffrida, et al. · Journal of Crohn s and Colitis
PDF
P439 Effectiveness of Ustekinumab on Crohn’s disease associated spondyloartropathy: real-world data from the Sicilian Network for Inflammatory Bowel Diseases (SN-IBD)
2021 · F Macaluso, W Fries, et al. · Journal of Crohn s and Colitis
T04.01.19 Ustekinumab in Crohn's Disease: Real-world Outcomes From the Sicilian Network for Inflammatory Bowel Diseases (sn-ibd) – Preliminary Results
2020 · A. Centritto, G. Fiocco, et al. · Digestive and Liver Disease
Oc.12.1 Sposib Sb2 - a Sicilian Prospective Observational Study of Patients With Inflammatory Bowel Disease Treated With Infliximab Biosimilar Sb2
2020 · F.S. Macaluso, W. Fries, et al. · Digestive and Liver Disease
T04.02.21 Loss of Response After First Line Anti-tnf Therapy in Patients With Inflammatory Bowel Disease: Pratical Approach and Management
2020 · S. Guella, B. Scrivo, et al. · Digestive and Liver Disease
T04.01.11 Prevalence of Nafld (non Alcoholic Fatty Liver Disease) in Inflammatory Bowel Disease: the Impact of Traditional Risk Factors, Intestinal Inflammation and Genetic Phenotype
2020 · B. Scrivo, C. Celsa, et al. · Digestive and Liver Disease
Works count: 37
Citation count: 146
H-index: 7
I10-index: 4
Year
Topic
Type